Products
Signal Tracker Data Platform Data Enrichment API Intelligence deskSolutions
Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For InvestorsExplore
Companies Live Signals Markets TrendsResources
Signal Checker Blog Integrations FAQ Contact Pricing
South San Francisco, United States
33 employees
Post Ipo Debt
Total: $294.89M
Biotechnology, Health Care
Get notified when UNITY Biotechnology moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksUnited States Market
Biotechnology
As pioneers in cellular senescence, UNITY is at the forefront of advancing the first senolytic therapeutic candidate for retinal diseases. The aim is to restore diseased tissue to a healthier state, potentially revolutionizing treatment in ophthalmology.
The company secured a significant $4.30M post-IPO debt investment on 10 November 2023, demonstrating confidence in its innovative approach and potential for transformative impact within the biotechnology and healthcare industries.
Taxonomy: therapeutics, diseases of aging, senescent cells, age-related ophthalmologic diseases, neurologic diseases, senolytic medicines, senolytic therapy, aging research, pharmaceuticals, biomedical innovations
| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | - | 10 Nov 2023 | |
| Post-IPO Debt | •••••• | 1 |
|
04 Aug 2020 |
| Series C | •••••• | 10 |
|
19 Mar 2018 |
| Series B | •••••• | 10 |
|
17 Aug 2017 |
| Series B | •••••• | 7 |
|
27 Oct 2016 |
Powering relentless science by developing and commercializing first-in-class treatments to address d...
Gene therapy company for inherited retinal diseases
EyeCheckup is an early diagnosis system for preventing vision loss using artificial intelligence.
vs
Associated Retina Consultants
Signal Tracker monitors UNITY Biotechnology and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
One analytics cookie (Google Analytics). We use a single analytics cookie (Google Analytics) to understand how the site is used. Essential cookies are always on. You decide on analytics. Cookie Policy
